Surface-displayed cholesterol enhances penetration and anti-tumor activity of a platinum nanodrug by targeting NPC1L1-expressing cancer associated fibroblasts. [PDF]
He P +9 more
europepmc +1 more source
Site-specific cholesterol depletion therapy for gastric cancer. [PDF]
Kavrakova S +5 more
europepmc +1 more source
Hybutimibe, an innovative cholesterol absorption inhibitor for lipid-lowering therapy: current evidence and future perspectives. [PDF]
Li S, Liu HH, Li JJ.
europepmc +1 more source
Qige decoction ameliorates hyperlipidemia in rats by modulating the intestinal microbiota and liver metabolism. [PDF]
Zunming Z +4 more
europepmc +1 more source
NPC1L1, A PHARMACOLOGICAL TARGET OF DYSLIPIDEMIA
Takada, Tappei +2 more
openaire +1 more source
Sulforaphane Attenuates Antipsychotic-Elicited Hypercholesterolemia Through Inhibition of Pregnane X Receptor. [PDF]
Pan J +5 more
europepmc +1 more source
Rare variants in cholesterol transporter genes in patients with lipid metabolism disorders. [PDF]
Izyumchenko AD +10 more
europepmc +1 more source
Lipid-lowering drugs and essential hemorrhagic thrombocythemia's risk: A drug-target Mendelian randomization study. [PDF]
Zhang P +8 more
europepmc +1 more source
Curcumin in Atherogenic Dyslipidemia: Linking Preclinical Mechanistic Insights to Clinical Outcomes. [PDF]
Brodziński K +3 more
europepmc +1 more source
Increased LDL-C reduction with ezetimibe in ketogenic diet-induced hypercholesterolemia. [PDF]
Gonzalez J +6 more
europepmc +1 more source

